Description

Lamotrin-25 Tablets 25 mg. №60

Composition:

Each tablet contains 25 mg of Lamotrigine.

Mechanism of Action:

Lamotrigine acts by stabilizing neuronal membranes and inhibiting the release of excitatory neurotransmitters, thus exerting antiepileptic effects.

Pharmacological Properties:

Lamotrigine exhibits anticonvulsant activity by modulating voltage-gated sodium channels and reducing the release of glutamate, thereby suppressing abnormal neuronal firing.

Indications for Use:

Lamotrin-25 tablets are indicated for the management of epilepsy in both adult and pediatric patients. They can be administered as monotherapy or as adjunctive therapy with other antiepileptic drugs.

Contraindications:

Avoid using Lamotrin-25 tablets if you have a known hypersensitivity to lamotrigine or any of the tablet components. Prior consultation with a healthcare provider is essential before initiating treatment.

Side Effects:

Common adverse reactions associated with Lamotrin-25 tablets include dizziness, drowsiness, and headache. Severe side effects like skin rash or mood disturbances should be promptly reported to a healthcare professional.

Usage Instructions:

Administer Lamotrin-25 tablets orally as per the healthcare provider’s instructions. The initial dosage is usually low and is titrated gradually to achieve optimal therapeutic outcomes. Tablets should not be crushed or chewed.

Benefits Compared to Analogues:

Lamotrin-25 tablets offer a favorable efficacy and safety profile compared to other antiepileptic medications. The gradual titration schedule helps minimize adverse effects while maximizing seizure control.

Suitable Patient Groups:

Lamotrin-25 tablets are suitable for use in various patient populations, including children and elderly individuals. Dose adjustments may be necessary based on age and renal function.

Storage and Shelf Life:

Store Lamotrin-25 tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the tablets beyond the specified shelf life.

Packaging Description:

Lamotrin-25 tablets are packaged in blister packs containing 60 tablets each. The packaging is designed to protect the tablets from moisture and external contaminants.

Clinical Evidence and Proven Effectiveness:

Lamotrigine’s efficacy in epilepsy treatment is supported by extensive clinical research. Studies, such as those published in reputable journals like the Journal of Neurology, have demonstrated the drug’s effectiveness in reducing seizure frequency and improving quality of life in epilepsy patients.